Volume 1, Issue 1 (Vaccine Research 2014)                   vacres 2014, 1(1): 28-30 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Arsang A, Yari S, Masoumi M, Nour Neamatollahi A, Vaziri F, Nejati M, et al . Extraction and Purification of Haemophilus influenzae Type b Lipooligosac‌charide by Modified Phenol Method. vacres 2014; 1 (1) :28-30
URL: http://vacres.pasteur.ac.ir/article-1-28-en.html
Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran, Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
Abstract:   (20472 Views)

  Introduction : Haemophilus influenzae type b (Hib) is a Gram negative bacterium and one of the causative agents of acute bacterial meningitis, especially in infants and children less than 5 years old. Lipooligosaccharide (LOS), one of the virulence factors which plays an important role in pathogenesis of Hib, has multiple applications in diagnosis and conjugate vaccines. In this study, LOS extracted from two Hib standard strains (ATCC 39930 and ATCC 10214) were compared. Material and methods: LOS was extracted by a modified hot phenol method from the aqueous and phenol phase and its concentration and purity assayed . Protein c ontaminations of the samples were determined spectrophotometrically and their endotoxin contents were assayed by the Limulus amebocyte lysate (LAL). Result and Discussion: The yield of the extracted LOS from strain ATCC10214 was about 475 μg/ml and the protein contaminations of the samples were approximately 0.07 mg/ml, whereas strain ATCC39930 yielded 520 μg/ml of LOS with protein contamination of 0.08 mg/ml. The results showed that the production of LOS by both strains was similar and the variation observed was not statistically significant (p < 0.001). Vac Res , 2014, 1 (1): 29-31

Full-Text [PDF 445 kb]   (3064 Downloads)    
Type of Study: Original article |
Received: 2014/02/16

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.